Enhanced glucose transport, but not phosphorylation capacity, ameliorates lipopolysaccharide-induced impairments in insulin-stimulated muscle glucose uptake

Shock

Volumn 45, Issue 6, 2016, Pages 677-685

  Otero, Yolanda F ^a   Mulligan, Kimberly X ^a   Barnes, Tammy M ^a,c   Ford, Eric A ^a,b   Malabanan, Carlo M ^a   Zong, Haihong ^a   Pessin, Jeffrey E ^a   Wasserman, David H ^a   McGuinness, Owen P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardiac output; Endotoxin; Inflammation; Insulin resistance

Indexed keywords

FATTY ACID; GLUCOSE TRANSPORTER 4; HEXOKINASE; INSULIN; LACTIC ACID; LIPOPOLYSACCHARIDE; PYRUVATE DEHYDROGENASE KINASE 4; GLYCOGEN; MUSCLE PROTEIN;

ANAEROBIC GLYCOLYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; HEART FUNCTION; IN VIVO STUDY; INSULIN RESISTANCE; MOUSE; MUSCLE GLUCOSE UPTAKE; NONHUMAN; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; C57BL MOUSE; DISEASE MODEL; GLUCOSE BLOOD LEVEL; METABOLISM; PHOSPHORYLATION;

ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; INSULIN; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHOSPHORYLATION;

EID: 84950120104     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000550     Document Type: Article

References (35)

1. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, et al.: The NICE-SUGAR Study Investigators: Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med 360(13):1283-1297, 2009.
2. van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 354(5):449-461, 2006.
3. Elia M, De Silva A: Tight glucose control in intensive care units: an update with an emphasis on nutritional issues. Curr Opin Clin Nutr Metab Care 11(4):465-470, 2008.
4. Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, et al.: Hypoglycemia and risk of death in critically ill patients. N Engl J Med 367(12):1108-1118, 2012.
5. Mulligan KX, Morris RT, Otero YF, Wasserman DH, McGuinness OP: Dis-association of muscle insulin signaling and insulin-stimulated glucose uptake during endotoxemia. PLoS One 7(1):e30160, 2012.
6. Lang CH, Dobrescu C, Meszaros K: Insulin-mediated glucose uptake by individual tissues during sepsis. Metabolism 39(10):1096-1107, 1990.
7. Fan J, Li YH, Wojnar MM, Lang CH: Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. Shock 6(3):164-170, 1996.
8. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Wasserman DH: Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation. Am J Physiol Endocrinol Metab 286(1):E77-E84, 2004.
9. Baron AD, Laakso M, Brechtel G, Edelman SV: Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 73(3):637-643, 1991.
10. Charron MJ, Gorovits N, Lai JS, Ranalletta M, Katz EB: Use of GLUT-4 null mice to study skeletal muscle glucose uptake. Clin Exp Pharmacol Physiol 32(4):308-313, 2005.
11. Lombardi AM, Moller D, Loizeau M, Girard J, Leturque A: Phenotype of transgenic mice overexpressing GLUT4 and hexokinase II in muscle. FASEB J 11(13):1137-1144, 1997.
12. Braithwaite SS, Palazuk B, Colca JR, Edwards CW 3rd, Hofmann C: Reduced expression of hexokinase II in insulin-resistant diabetes. Diabetes 44(1):43-48, 1995.
13. Fueger PT: Glucose phosphorylation as a barrier to muscle glucose uptake. Clin Exp Pharmacol Physiol 32(4):314-318, 2005.
14. Olson AL, Liu ML, Moye-Rowley WS, Buse JB, Bell GI, Pessin JE: Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J Biol Chem 268(13):9839-9846, 1993.
15. Chang PY, Jensen J, Printz RL, Granner DK, Ivy JL, Moller DE: Overexpression of hexokinase II in transgenic mice. Evidence that increased phosphorylation augments muscle glucose uptake. J Biol Chem 271(25):14834-14839, 1996.
16. Ayala JE, Bracy DP, Malabanan C, James FD, Ansari T, Fueger PT, McGuinness OP, Wasserman DH: Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. J Vis Exp 57:e3188, 2011.
17. Lloyd B, Burrin J, Smythe P, Alberti KG: Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 24(10):1724-1729, 1978.
18. Zong H, Wang C-C, Vaitheesvaran B, Kurland IJ, Hong W, Pessin JE: Enhanced energy expenditure, glucose utilization and insulin sensitivity in VAMP8 null mice. Diabetes 60:30-38, 2011.
19. House LM 2nd, Morris RT, Barnes TM, Lantier L, Cyphert TJ, McGuinness OP, Otero YF: Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance. Cardiovasc Diabetol 14:56, 2015.
20. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ: Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45(1):28-36, 1996.
21. Fueger PT, Shearer J, Bracy DP, Posey KA, Pencek RR, McGuinness OP, Wasserman DH: Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice. J Physiol 562(pt 3):925-935, 2005.
22. Deems R, Evans J, Deacon R, Honer C, Chu D, Bürki K, Fillers W, Cohen D, Young D: Expression of human GLUT4 in mice results in increased insulin action. Diabetologia 37(11):1097-1104, 1994.
23. Tsao TS, Li J, Chang KS, Stenbit AE, Galuska D, Anderson JE, Zierath JR, McCarter RJ, Charron MJ: Metabolic adaptations in skeletal muscle over-expressing GLUT4: effects on muscle and physical activity. FASEB J 15(6):958-969, 2001.
24. Ren JM, Marshall BA, Mueckler MM, McCaleb M, Amatruda JM, Shulman GI: Overexpression of GLUT4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest 95(1):429-432, 1995.
25. Lu B, Moser AH, Shigenaga JK, Feingold KR, Grunfeld C: Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response. J Lipid Res 47(10):2179-2190, 2006.
26. Zu L, He J, Jiang H, Xu C, Pu S, Xu G: Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway. J Biol Chem 284(9):5915-5926, 2009.
27. Grumbach IM, Chen W, Mertens SA, Harrison DG: A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol 39(4):595-603, 2005.
28. Liang CF, Liu JT, Wang Y, Xu A, Vanhoutte PM: Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol 33(4):777-784, 2013.
29. Oliveira-Paula GH, Lacchini R, Tanus-Santos JE: Inducible nitric oxide syn-thase as a possible target in hypertension. Curr Drug Targets 15(2):164-174, 2014.
30. Nohara A, Okada S, Ohshima K, Pessin JE, Mori M: Cyclin-dependent kinase-5 is a key molecule in tumor necrosis factor-alpha-induced insulin resistance. J Biol Chem 286(38):33457-33465, 2011.
31. Zhao P, Turdi S, Dong F, Xiao X, Su G, Zhu X, Scott GI, Ren J: Cardiac-specific overexpression of insulin-like growth factor I (IGF-1) rescues lipopolysacchar-ide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes. Shock 32(1):100-107, 2009.
32. Tian R, Abel ED: Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 103(24):2961-2966, 2001.
33. Hruz PW, Yan Q, Struthers H, Jay PY: HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy. FASEB J 22(7):2161-2167, 2008.
34. Mittwede PN, Xiang L, Lu S, Clemmer JS, Hester RL: Oxidative stress contributes to orthopedic trauma-induced acute kidney injury in obese rats. Am J Physiol 308(2):26, 2015.
35. Drosatos K, Drosatos-Tampakaki Z, Khan R, Homma S, Schulze PC, Zannis VI, Goldberg IJ: Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction. J Biol Chem 286(42):36331-36339, 2011.